GA4 (398745346)

The first China Preventive Medicine Innovation Summit and Meinian Health Innovation and Development Forum were held in Beijing, boosting the high-quality development of China’s preventive medicine industry

The first China Preventive Medicine Innovation Summit and Meinian Health Innovation and Development Forum were held in Beijing, boosting the high-quality development of China’s preventive medicine industry


From April 15th to 16th, the first China Preventive Medicine Innovation Summit and Meinian Health Innovation Development Forum were held in Beijing. At the summit, the China Health Management Association announced the establishment of the “Organ Function Quantification Management Branch of the China Health Management Association”. The summit is guided by the China Health Management Association, co-hosted by Meinian Health Group and the Organ Function Quantification Management Branch of the China Health Management Association. Industry associations, many well-known academicians and experts in the medical field, presidents of well-known colleges, presidents of tertiary hospitals, chief physicians, professors, core strategic partners of the Meinian Health Group ecosystem, and other backbone forces in various fields of the big health industry and representatives of mainstream media totaled 1,000 Others attended the summit.

The first China Preventive Medicine Innovation Summit is the first time that China’s preventive medicine industry is held with the theme of “innovation”. It gathers academicians and experts with significant influence in the industry and has a high academic level. At this summit, the leaders of the association, experts and scholars closely focused on implementing the national strategy of healthy China, focusing on the opportunities and challenges faced by the development of preventive medicine and the development of the big health industry in the new era, especially chronic diseases under the trend of population aging and the prevention and management of major diseases, shared the latest achievements and health management solutions in their respective research fields, and advocated the use of innovative spirit, innovative methods, and innovative technologies to promote the high-quality development of preventive medicine in my country.

“Organ Function Quantification Management Branch of China Health Management Association” was formally established

At the summit site, the inauguration ceremony of the “Organ Function Quantification Management Branch of China Health Management Association” was held. Li Ming, Vice President of China Health Management Association, Guo Yike, Academician of Royal Academy of Engineering, Academician of European Academy of Sciences, Academician of Hong Kong Academy of Engineering Sciences, President of Organ Function Quantitative Management Branch, Director of National Geriatrics Center, Former President of Beijing Hospital Wang Jianye, Vice President of Branch Chairman Zhang Junjian, chief expert and vice president of the Department of Neurology, Zhongnan Hospital of Wuhan University; branch secretary Lu Jianping, honorary director of the Imaging Medicine Department of the First Affiliated Hospital of Naval Military Medical University; Jiang Sunfang, director of the Health Management Center of Zhongshan Hospital Affiliated to Fudan University; Meinian Health Group Chairman Yu Rong, Vice Chairman of Meinian Health Group Guo Meiling, President of Meinian Health Group Xu Tao, Founder and CEO of Jingsan Technology Shen Yiling and other leaders and experts attended.

The launching ceremony of “Organ Function Quantification Management Branch of China Health Management Association”

The Organ Function Quantitative Management Branch of the China Health Management Association is the first professional organization in China that focuses on the quantitative management of organ function. The clinical application of functional assessment can promote the prevention of major diseases and help realize an intelligent and efficient health management model.

Li Ming, vice president of the China Health Management Association, said in a speech: “The reality of accelerated population aging has added to the sense of urgency for the Chinese medical system to shift from emphasizing treatment to both prevention and treatment. What we are pursuing is not only to prolong life, but to prolong healthy life. The work of the Organ Function Quantitative Management Branch will adhere to people-centered, prevention-centered, guided by the vision of Healthy China 2030, linking enterprises, governments and academic institutions, in order to improve the national disease risk control system and innovate an intelligent and efficient health management system Make your own contribution.”

Li Ming, Vice President of China Health Management Association delivered a speech

Wang Jianye, president of the Quantitative Management of Organ Function Branch, director of the National Center for Geriatrics, and former president of Beijing Hospital, delivered a speech on the theme of “Common Diseases of the Elderly in China-Current Status and Challenges of Chronic Diseases”. He pointed out that the promotion of healthy aging is actually part of the “Healthy China 2030 Planning Outline”. At present, the health status of the elderly in my country is not optimistic. Elderly comorbidities will increase service costs, affect the health and quality of life of the elderly population, and significantly reduce the survival rate of elderly patients. The guiding principles for coping with the challenges faced by comorbidities in the elderly include: patient-centered care of the whole person, emphasizing holistic and individualized care; the goal is to improve the functional status and quality of life of the elderly; the treatment of comorbidities is not The superposition of disease diagnosis and treatment should be considered comprehensively according to the specific conditions of elderly patients.

Wang Jianye, President of the Organ Function Quantification Management Branch, Director of the National Geriatrics Center, and Former President of Beijing Hospital, delivered a speech

Fan Daiming, academician of the Chinese Academy of Engineering and honorary president of the Organ Function Quantification Management Branch of the China Health Management Association, expressed congratulations on the establishment of the “Organ Function Quantification Management Branch of the China Health Management Association” through a video. He said that the natural power of the human body is formed by the coordination and joint operation of different organs of the human body. The Chinese Health Management Society established the Organ Function Quantitative Management Branch, which aims to use quantitative analysis methods to evaluate the role of a specific organ in the overall health of the human body and the formation of human natural forces, which is of great significance.

Video Speech by Fan Daiming, academician of the Chinese Academy of Engineering and honorary president of the Organ Function Quantification Management Branch of the China Health Management Association

Meinian Health held an innovation and development forum at the same time, proposing the development goal of becoming a leading technology enterprise in the field of preventive medicine

At the forum, all participating experts and professors delivered forward-looking speeches based on their respective research fields, bringing to this forum the most cutting-edge scientific research results, the most advanced experience and the broadest experience in the fields of disease screening and diagnosis and treatment, and health management. The field of vision has brought new ideas and new inspirations to the development of my country’s preventive medicine industry.

Professor Guo Yike, academician of the Royal Academy of Engineering, academician of the European Academy of Sciences, academician of the Hong Kong Academy of Engineering Sciences, and chief vice-president of the Hong Kong University of Science and Technology, published a speech titled “Prevention Is Better Than Cure: How Big Data and AI Can Drive a Healthcare Revolution”. : How big data and artificial intelligence drive the human health revolution)” theme sharing, he said that in the era of Chat GPT artificial intelligence, the importance of big data to medical health is no longer a future, not a research topic, but a real in reality. The application of information in the field of preventive medicine is reflected in intelligent physical examination, health management, health promotion and precision treatment. Among them, the most important thing in preventive medicine is detection. Academician Guo Yike said that participating in the research and development of Jingsan Technology, through the combination of artificial intelligence and MRI, the establishment of a brain health risk model can tell us how to improve brain health. This technology is the “Brain Ruijia” brain cognition and stroke risk intelligent assessment product jointly developed and launched by Meinian Health Group and Jingsan Technology.

Professor Guo Yike, Academician of the Royal Academy of Engineering, Academician of the European Academy of Sciences, Academician of the Hong Kong Academy of Engineering Sciences, and Chief Vice-President of the Hong Kong University of Science and Technology delivered a speech

Professor Li Zhaoshen, an expert in gastroenterology and academician of the Chinese Academy of Engineering, published an academic sharing on the theme of “20 Years of Clinical Research on Chronic Pancreatitis”, presenting his fruitful research results in the field of chronic pancreatitis. Academician Li Zhaoshen said that after 20 years of systematic extracorporeal shock wave lithotripsy for chronic pancreatitis and some research on ERCP treatment, the academician Li Zhaoshen’s team has achieved great success in terms of extracorporeal shock wave lithotripsy, indications and prevention of complications. All have done systematic research and been well verified. Looking back on the research over the past 20 years, Academician Li Zhaoshen’s team clarified the etiology and natural course of the disease, established a new system of minimally invasive treatment, and also revealed some genetic backgrounds, disease-medicine relationships, formed a large research team, took the lead in carrying out extracorporeal shock wave lithotripsy and obtained extremely good results. With high efficacy and safety, it solves a series of problems in the treatment of chronic pancreas.

Professor Wang Hongyang, an expert oncologist and academician of the Chinese Academy of Engineering, published an academic report entitled “Focusing on Clinical Problems, Emphasizing Application and Transformation”. She pointed out that malignant tumors are a severe challenge to the construction of a healthy my country. Early diagnosis and early treatment, scientific research and public relations have been included in the government’s work report. Early prevention and precise treatment of tumors is a major global health need. Liver cancer, gastric cancer, and colorectal cancer, which have a relatively high incidence in my country, all have the characteristics of precancerous lesions. At the same time, the incidence of cancer in my country continues to increase, and it is showing a trend of rejuvenation. Strengthening early diagnosis and screening is the key to deal with the rejuvenation of cancer.

Yu Rong, chairman of Meinian Health Group, delivered a speech on the theme of “Innovative Technology Leads the New Journey of Meinian”. The four major scientific and technological changes, health management represented by wearable devices and early screening technology around new targets, can analyze a large amount of health data, identify disease risks and provide personalized health advice, bringing new opportunities to the development of preventive medicine. opportunity. In recent years, Meinian Health has been constantly innovating, actively embracing technological changes, continuously introducing and developing innovative technological products, and has done a lot of research and development work in innovative technologies, and has made some achievements, such as launching AI segmentation of brain regions with the help of AI technology A series of innovative medical examination products such as reconstructed brain health screening, AI identification and extraction calculation of coronary artery calcification score, AI-based X-ray bone density screening, AI fundus photographic analysis, AI evaluation of pulmonary nodules “Feijiening”, and With the help of new technologies such as wearable devices, blood glucose management products with continuous 14-day blood glucose monitoring were launched, with the help of genetic testing technology, the early screening product for colorectal cancer with Septin9 gene methylation was launched, and a new marker of gastrointestinal cancer was launched with the help of new marker detection technology Secreted protein (CST4) detection and other black technology innovative products. The future development goal of Meinian Health is to become a technological leader in the field of preventive medicine through continuous innovation. “New standard, new technology, new journey” are the three core themes of Meinian Health. Meinian’s “new technology” includes information technology IT, data technology DT, artificial intelligence AI, and wearable device IoT. Meinian Health is about to launch a vascular health package based on gene chip technology, which can realize the assessment of the congenital risk of blood vessels and the risk in the next 10 years. In terms of health management, Meinian Health will deeply integrate the concept, technology and products of traditional Chinese medicine “preventive treatment” through AI empowerment, improve the efficiency of traditional Chinese medicine physical examination, and realize the implementation of intelligent health management of traditional Chinese medicine. Implementing the AIGC strategy is a major goal of the new journey. Meinian Health Research Institute is cooperating with relevant scientific research institutes to start the application research based on AIGC technology in the health examination industry, give full play to the advantages of Meinian health data, and realize productization as soon as possible, including Intelligent main examination, interpretation of physical examination reports, digital healthy person, virtual health consultant, intelligent customer service, etc., bring more convenience and value-added services to physical examination customers.

Yu Rong, chairman of Meinian Health Group, delivered a speech

Guo Meiling, vice chairman of Meinian Health Group, delivered a concluding speech. She sincerely thanked the China Health Management Association for its comprehensive guidance and strong support for this summit, and thanked all the leaders, experts, professors and many suppliers present for their support to the conference. She said that in the field of preventive medicine that focuses on front-end disease prevention, only by continuously achieving scientific and technological innovation breakthroughs can we better build a healthy China and a technologically powerful country, and create more health and well-being for the people. The significance of the Innovation Summit and the Meinian Health Innovation and Development Forum. As a leading company in my country’s health industry, Meinian Health will always be committed to the innovative development of preventive medicine and health services in the future, with digital intelligence as the development engine, and a digital service platform for health checkup and life health (digital twins for life and health) as the Two-wheel drive, steady development. We will take this summit as an opportunity to further strengthen cooperation and work together to promote the prosperity and development of China’s preventive medical and health industry!

Guo Meiling, Vice Chairman of Meinian Health Group delivered a concluding speech

Xu Tao, President of Meinian Health Group, delivered a speech themed “Forging the Foundation of Digital Transformation and Pioneering the Road to Product Innovation”. future trends. Information management, digital marketing, and intelligent services will change the service model of health checkups. “Product innovation, operation innovation and discipline innovation” will be the overall development route of Meinian Health’s innovation work in the next three years. In the future, Meinian Health will continue to take “innovation + technology” as the core drive, relying on discipline construction and artificial intelligence technology, and continue to launch “specialized, special and new” medical examination innovations covering the entire life cycle of customers, including “medical examination and storage” Products, to further meet the public’s demand for high-quality health, and escort customers’ health management throughout the life cycle. Meinian Health will combine internal data and external knowledge to develop personalized physical examinations driven by AI algorithm models, optimize personalized physical examinations and group examinations with digital intelligence, and create an all-round life cycle that implements pre-examination, examination, and post-examination digital health management platform.

Xu Tao, President of Meinian Health Group delivered a speech

In addition, Professor Fan Xing, Deputy Director of Plastic Surgery, Xijing Hospital, Air Force Military Medical University, Professor Zhang Junjian, Chief Expert and Vice President of Department of Neurology, Zhongnan Hospital, Wuhan University, Secretary General of Organ Function Quantitative Management Branch of China Health Management Association, First Affiliated to Naval Military Medical University Professor Lu Jianping, honorary director of the Department of Imaging Medicine of the hospital; Professor Jiang Sunfang, director of the Health Management Center of Zhongshan Hospital affiliated to Fudan University; Professor Wang Yu, deputy director of the Liver Disease Center of Beijing Friendship Hospital affiliated to Capital Medical University; Chief Physician of Medical Imaging Department, Graduate Tutor, Deputy Director of Imaging Teaching and Research Section Professor Cao Wei, Associate Professor Huang Zheng, Institute of Psychology, Chinese Academy of Sciences, Professor Xue Zhong, Distinguished Researcher of School of Biomedical Engineering, ShanghaiTech University, Director of Beijing Guoke Small and Medium-sized Enterprise Science and Technology Development Foundation Chang Song Wenming presented “New Model of Neuralgia Treatment in Dermatology”, “Vascular Factors of Dementia and Its Intervention Strategies”, “Opening a New Model of Abdominal CT Screening in the Age of Artificial Intelligence”, “Innovation and Integration – Infinite Health Management Ecology” “, “Liver Health Management and Chronic Liver Disease Prevention”, “Clinical Application of Coronary MRA Without Contrast Agent”, “Application of MR Technology in Breast Diseases”, “Relationship and Important Application of Mental Health and Enterprise Development and Personal Health” , “Model Innovation and Application of Imaging AI”, and “Innovative Integrated Service Model Helps the Development of Medical Science and Technology Innovation Enterprises” to publish academic reports and share.



Source link